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584Objective: To demonstrate the efficacy of a minimally invasive, nonoperative, catheter-based approach to the
treatment of traumatic chyle leak.
Methods: A retrospective review of 109 patients was conducted to assess the efficacy of thoracic duct emboli-
zation or interruption for the treatment of high-output chyle leak caused by injury to the thoracic duct.
Results: A total of 106 patients presented with chylothorax, 1 patient presented with chylopericardium, and 2
patients presented with cervical lymphocele. Twenty patients (18%) had previous failed thoracic duct ligation.
In 108 of 109 patients, a lymphangiogram was successful. Catheterization of the thoracic duct was achieved in
73 patients (67%). In 71 of these 73 patients, embolization of the thoracic duct was performed. Endovascular coils
or liquid embolic agent was used to occlude the thoracic duct. In 18 of 33 cases of unsuccessful catheterization,
thoracic duct needle interruption was attempted below the diaphragm. Resolution of the chyle leak was observed
in 64 of 71 patients (90%) post-embolization. Needle interruption of the thoracic duct was successful in 13 of 18
patients (72%). In 17 of the 20 patients who had previous attempts at thoracic duct ligation, embolization or
interruption was attempted and successful in 15 (88%). The overall success rate for the entire series was 71%
(77/109). There were 3 (3%) minor complications.
Conclusion: Catheter embolization or needle interruption of the thoracic duct is safe, feasible, and successful in
eliminating a high-output chyle leak in the majority (71%) of patients. This minimally invasive, although
technically challenging, procedure should be the initial approach for the treatment of a traumatic chylothorax.
(J Thorac Cardiovasc Surg 2010;139:584-90)Posttraumatic chylothorax remains a significant complica-
tion of thoracic, cardiac, and neck surgery. Chylothorax is
a particularly difficult complication to manage after esopha-
gectomy.1 Traditionally, low-output chylothorax (<1000
mL/d) is treated conservatively with total parental nutrition
or a medium-chain fatty acid diet.2 High-output chylothorax
usually mandates early surgical ligation via an open or video
technique.3,4 The mortality after conservative treatment of
chylothorax approaches 50% but decreases to 10% after
surgical repair.5,6 Recently, earlier intervention has been rec-
ommended to reduce mortality and morbidity.4
Percutaneous treatment of chylothorax was developed as
a minimally invasive alternative to surgical thoracic duct
ligation.7 The treatment consists of diagnostic pedal lymph-
angiography followed by transabdominal catheterization of
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The Journal of Thoracic and Cardiovascular Surgthoracic duct proximal to the chyle leak. In addition to the
minimally invasive nature of the procedure, the ability to
identify chyle leak and variations in thoracic duct anatomy
potentially improves the outcome. In the largest series of
42 patients, Cope and Kaiser7 reported 73.8% response rates
after thoracic duct embolization (TDE) and needle interrup-
tion with no morbidity or mortality. The objective of this
study is to summarize our latest experience with this proce-
dure as a treatment for traumatic chylothorax. Because of
significant differences in pathophysiology, diagnosis, treat-
ment, and outcome between nontraumatic and traumatic
chylothorax, we believe that these 2 distinct entities should
be reported, considered, and analyzed separately.MATERIALS AND METHODS
Institutional review board approval was obtained for this retrospective
review, and a Health Insurance Portability and Accountability Act waiver
was granted. Between 1996 and early 2009, 109 patients with chyle leaks
caused by iatrogenic injury were treated with TDE or thoracic duct interrup-
tion. Patient age, gender, location of the chylous effusion, treatment out-
come, and complications were collected retrospectively from hospital
databases and our quality assurance database (HI-IQ, Conexsys, Woon-
socket, RI).
All patients had the typical ‘‘milky’’ appearance of chylous effusion
obtained from drainage tubes or pleural tap. To confirm the diagnosis, the
levels of triglycerides and cholesterol were measured and defined as diag-
nostic when the triglyceride level was more than 110 mg/dL and the choles-
terol level was less than blood level.8ery c March 2010
FIGURE 1. Radiographic image showing attempt to access cysterna chyli
opacified with contrast (arrow) with 21-gauge needle.
Abbreviations and Acronyms
TDE ¼ thoracic duct embolization
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venous antibiotics (cefazolin) were administered before the procedure.
Diagnostic pedal lymphangiography was performed. To opacify a pedal
lymphatic vessel and facilitate lymphatic vessel dissection, Isosulfan blue
1% (Lymphazurin; US Surgical, Norwalk, Conn) mixed with lidocaine
1% was injected into the soft tissue of the web between the toes. After sev-
eral minutes, through a small horizontal incision on the dorsum of the foot,
a lymphatic duct was dissected free and cannulated using a 30-gauge nee-
dle (Cook Inc, Bloomington, Ind). Ethiodized oil (Ethiodol, Savage Labo-
ratories, Melville, NY) was then injected through the needle using
a dedicated lymphangiogram pump (Cordis, Johnson and Johnson, Miami
Lakes, Fla).
The amount of contrast injected depended on physician preference but
was generally not more than 15 mL. If the cisterna chyli could not be opa-
cified at the completion of the injection, 20mL of normal saline was injected
into the lymphatic vessels after the Ethiodol to propel the contrast through
the lymphatic vessels and facilitate opacification of the thoracic duct and cis-
terna chyli (a so-called push lymphangiogram).
After identification, the target vessel (cisterna chyli, thoracic duct, or one
of the tributaries) was accessed percutaneously using a 21- or 22-gauge 15-
to 20-cmChiba needle (Cook Inc) via a transabdominal approach (Figure 1).
Efforts were made to avoid access through the large intestine or aorta. Be-
cause of the absence of a suitable target in the upper abdomen, access was
achieved retrograde in 1 patient via direct puncture of the cervical portion of
the thoracic duct.
A stiff 0.018-inch guidewire (V18 Control, Boston Scientific, Natick,
MA) was advanced through the needle into the cisterna chyli and further
into the thoracic duct (Figure 2). A microcatheter (Rapid Transit, Cordis)
65 cm in length was advanced into the thoracic duct over the wire. Iodinated
water-soluble contrast was injected through the microcatheter to define the
leak (Figure 3). After identification of extravasation, embolization of the
thoracic duct below the leak was performed. Over the course of the study
period, different embolization materials were used to occlude the thoracic
duct. Embolization coils initially were used to pack the lumen of the thoracic
duct and impede flow. Later, with the availability of glue (TrueFill; Cordis)
and Onyx (Micro Therapeutics Inc, Irvine, Calif), these liquid agents alone
or in combination with intravascular coils were used (Figure 4). The True-
Fill glue was diluted 1:2.5 with Ethiodol to delay polymerization; Onyx was
used according to the manufacturer’s instructions. Immediately after glue
injection, the microcatheter was removed. If catheterization of the cisterna
chyli/thoracic duct was unsuccessful, needle interruption of the thoracic
duct below the diaphragmwas performed using a previously described tech-
nique.7
After the procedure, the output from drainage tubes was monitored, and
if it decreased significantly, a food challenge test (ice cream or cream) was
prescribed. If negative, the diet was advanced and the chest drains were re-
moved. In patients with a ‘‘slow leak’’ or without a chest tube, follow-up
chest radiography was used to monitor the success of the treatment. If em-
bolization was technically successful, but failed clinically, repeat emboliza-
tion was performed. In such cases, a repeat lymphangiogram was not
performed, because the glue/retained contrast was used to guide the access
into the cisterna chyli.RESULTS
Overall, 109 patients (54 male, 55 female, average age 59
years) were treated over a period of 13 years, 40 of whomThe Journal of Thoracic and Cawere referred from the outside facilities. A total of 106 pa-
tients presented with chylothorax, 1 patient presented with
chylopericardium, and 2 patients presented with chylous
leaks in the subcutaneous tissue of the neck. Among patients
with chylothorax, 47 of 106 (44%) presented with left effu-
sions, 46 of 106 (43%) presented with right effusions, and
13 of 106 (13%) presented with bilateral effusions. The
causes of the chylous leak are listed in Table 1. Twenty of
109 patients (18%) presented with previously unsuccessful
thoracic duct ligation.
Lymphangiography was successful in all but 1 patient
(108/109, 99%). In 2 of 108 patients, catheterization was
deemed impossible because of unsuitable anatomy and
was not attempted. In 73 of 106 patients (67%), catheteriza-
tion of the thoracic duct was successful. After successful
catheterization, TDE was performed in 71 of 73 patients.
In 2 patients in whom catheterization was successful, embo-
lization was not attempted because of the observation of
a successful (surgical) thoracic duct ligation. Later, we
learned that a radiographically successful ligation does not
imply clinical success and that even in such cases, emboliza-
tion of the cisterna chyli could result in clinical resolution of
the chylothorax.
Embolization was performed in 13 of 71 patients (18.3%)
with coils only; in 18 of 71 patients (25.4%) with liquid em-
bolic agents; and in 40 of 71 patients (56.3%) with a combi-
nation of liquid embolic agents and coils. In 18 of 33 cases of
unsuccessful catheterization, thoracic duct interruption was
performed.rdiovascular Surgery c Volume 139, Number 3 585
FIGURE 3. Radiographic image showing extravasation of the contrast in
the upper part of the thoracic duct (arrow), following injection of the duct
with iodinated contrast through the microcathetr.
FIGURE 2. Radiographic image showing V18 wire (arrow) in the cys-
terna chyli and thoracic duct.
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success rate for the entire series on intent-to-treat basis was
77 of 109 patients (71%). The overall success in the sub-
group of patients with attempted interventions (excluding pa-
tients in whom catheterization was not attempted [n ¼ 2],
embolization was not attempted [n ¼ 2], and interruption
was not attempted [n ¼ 17]) was 77 of 88 patients (88%).
Clinical success after technically successful TDE was 64
of 71 patients (90%) (4 patients with failures, 2 patients
were lost to follow-up, and 1 patient died within several
days post-procedure from unrelated causes). In 6 patients,
embolization was performed twice, after an initial unsuc-
cessful attempt. In all 6 patients, the second embolization at-
tempt was successful. The causes of failure were inadequate
filling of the lumen of the thoracic duct with liquid embolic
agent or coils.
In patients in whom liquid embolic agents were used, the
success of embolization was 53 of 58 patients (91%) (2
patients with failures, 2 patients with no follow-up, and 1
patient died within 1 week after embolization). The success
rate for coil only embolization was 11 of 13 patients (84%).
The clinical success of thoracic duct needle interruption was
13 of 18 patients (72%).
In the subgroup with failed thoracic duct ligation, TDE
was attempted in 17 of 20 patients. Intervention was not at-586 The Journal of Thoracic and Cardiovascular Surgtempted because of the radiographic appearance of the oc-
cluded cisterna chyli (1 patient with no catheterization
attempt and 2 patients with successful catheterizations, no
embolization attempt). As mentioned previously, these cases
were treated in the early investigational stages of this proce-
dure, and latter similar cases treated by embolization
resulted in cure. In this setting, embolization was successful
in 15 of 17 patients (88%).
There were 3 complications related to the procedure: 1
case of asymptomatic embolization of the pulmonary artery
with glue and 2 cases of leg edema and pedal sutureery c March 2010
FIGURE 4. Radiographic image showing the occluded thoracic duct filled
with coils (arrow) and glue cast below the colis.
TABLE 1. Causes of traumatic chylous leak
Esophagectomy 31
Lung resection for cancer 29
Coronary bypass 9
Thoracic aneurysm repair 6
Heart transplant 4
Trauma 4
Lung transplant 3
Aortic valve replacement 2
Mediastinal biopsy 2
Mediastinal mass resection 2
Cardiac tumor resection 2
Thyroidectomy 2
AAA repair 1
Aortic dissection repair 1
Aortic transection repair 1
Back surgery 1
Diaphragmatic hernia repair 1
Mitral valve replacement 1
Neck dissection for cancer 1
Neck dissection for lipoma 1
PDA ligations 1
Pericardial surgery 1
Radiation 1
Rib resection for thoracic outlet syndrome 1
Thymomectomy 1
Total 109
AAA, Abdominal aortic aneurysm; PDA, patent ductus arteriosus.
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eventually subsided, and the infections were cured with local
care and antibiotics.
DISCUSSION
Chylous effusion after operations involving the mediasti-
num and neck is a rare but serious complication with signif-
icant mortality and morbidity. It has been reported to occur
at a rate of 0.42% for all general thoracic surgery proce-
dures9 and up to 3.9% after esophagectomy.1 Traditionally,
low-output chylothorax (<1000 mL/d) is treated conserva-
tively by complete cessation of oral intake and administra-
tion of total parenteral nutrition or a medium-chain
triglycerides diet,9 and operative intervention is suggested
for cases with failure. In cases of high-output chylothorax
(>1000 mL/d), immediate reoperation with thoracic duct li-
gation has been recommended.9-11 The mortality after con-
servative treatment of chylothorax approaches 50% and
can reach 10%5,6 or 16% after surgical repair in high-risk
patients.12 Early intervention to stop chyle leakage has
been advocated recently to reduce perioperative mortalityThe Journal of Thoracic and Caand morbidity.4 Indeed, prolonged leakage of chyle, rich
in nutrients, T cells, and electrolytes, in the early postopera-
tive period can significantly worsen a patient’s condition.9
This report represents our latest experience with TDE and
thoracic duct needle interruption for traumatic chylothorax.
The procedure was designed and developed over the years
by Cope and Kaiser7 and Cope.13-15 Since its original de-
scription, several authors have reported their experience in
case reports and small series.16-21 The rationale for the pro-
cedure is to improve the success rate of thoracic duct inter-
ruption by using lymphangiography as a ‘‘road map’’ and
to reduce perioperative mortality and morbidity by using
a percutaneous, minimally invasive approach.
Lymphangiography has been used extensively to diag-
nose chylous leaks and define thoracic ductal anatomy be-
fore operation and especially in cases of failed thoracic
duct ligation.9,22-24 In our series, 20 patients were referred
after failed surgical thoracic duct ligation. In all of these
cases, lymphangiography could identify and guide treatment
that was successful in 90% of the subgroup in whom inter-
vention was attempted. Even in cases of failed TDE, the abil-
ity to identify the leak and underlying thoracic duct anatomy
facilitated and guided a subsequent surgical approach.
After initial encouraging reports of high success, low
complication rates of TDE/needle interruption,7 and a plea
for ‘‘early thoracic duct intervention,’’4 patients are referredrdiovascular Surgery c Volume 139, Number 3 587
FIGURE 5. Catheterization success of the cisterna chyli over the years.
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thorax at the Hospital of the University of Pennsylvania,
without distinction between high and low output.
The minimally invasive nature of the procedure is re-
flected in significantly lower morbidity and mortality after
TDE. In the original surgical series, mortality and morbidity
rates were 2.1% and 38%, respectively.9 We observed only
3 minor complications of the procedure in this study. This
correlates well with previous reports by Cope and Kaiser,7
who reported no complications, and Boffa and colleagues,21
who reported 1 case of bile leakage. The latter group used
a transhepatic approach and a larger 4F cannula to access
the cisterna chyli. We think that a transabdominal approach
with 21- to 22-gauge Chiba needles followed by 3F micro-
catheters represents a safer option. We did not observe any
complication related to transabdominal access, even though
it was through all upper abdominal structures. An additional
advantage of the procedure is the ability to perform it under
local anesthesia and moderate sedation without general an-
esthesia and single-lung ventilation. In some cases, TDE
was performed as a 1-day admission procedure.
One of the limitations of this study is its retrospective na-
ture; thus, it is possible that a few minor complications were
missed because some patients were transferred to our facility
for the procedure only and the clinical follow-up was per-
formed in the outside hospital. However, we believe that
we would be aware of significant complications related to
the procedure had they occurred
The overall success rate (intent to treat) in our series was
71%, which is comparable to 73.5% (partial and complete
response) reported by Cope and Kaiser7 and better than
45% reported by Boffa and colleagues.21 The slightly lower
success rate compared with that reported by Cope and Kaiser
could be explained by the fact that the intervention was at-
tempted in only 88 of 109 (80%) of our patients. Of note,
in the patient subgroup with attempted interventions the suc-
cess rate was 77 of 88 patients (88%).
The success rate is directly related to the ability to cathe-
terize the cisterna chyli/thoracic duct; when the catheteriza-
tion was successful, the cure rate was 90%. Several factors
affect the success of catheterization, including the ability to
visualize the cisterna chyli/thoracic duct, the patient’s body
habitus, and operator experience. Because of high flow in
the intestinal lymphatics, which constitutes 80% of the
lymphatic flow in the thoracic duct, contrast that reaches
the cisterna chyli through the lumbar lymphatics becomes
diluted at the level of their convergence. To deliver a signif-
icant bolus of contrast to the area of cisterna chyli, later in
our experience, we followed the injection of contrast with
a saline bolus (in patients in whom the target could not be
identified at the end of contrast injection). This was to pro-
pel intralymphatic contrast material further to the level of
cisterna chyli and to improve identification of the target ves-
sel. The overall success of catheterization was 67% in our588 The Journal of Thoracic and Cardiovascular Surgseries and 62% in Cope and Kaiser’s7 report. Operator ex-
perience plays a significant role in the success of the cisterna
chyli catheterization, which is reflected in Figure 5. Up to
2003, a single operator performed the bulk of the proce-
dures, and the success rate gradually reached 91%. New
operators started to perform the procedure in 2003, and
the success rate decreased to 54% and slowly increased to
84% in 2008 and 2009.
Although we see the thoracic duct interruption as a ‘‘last
resort’’ in case of failed thoracic duct catheterization, it was
proven to be somewhat effective, resulting in resolution in
72% of cases in our series, which is comparable to the
43% reported by Cope and Kaiser.7 Lymphangiography it-
self can result in cessation of chylothorax, as was reported by
Matsumoto and colleagues.25
We strongly believe that use of a combination of coils and
liquid embolic agent is necessary to achieve safe and ade-
quate closure of the thoracic duct. Coils serve as a matrix
for glue polymerization and provide an additional safety
measure in case of glue failure. Embolization with coils
alone results in higher failure rates when compared with
liquid embolic agents (84% vs 91%).
Two patients who were referred from the outside facility
were lost to follow-up, which is the major limitation of
this study.
CONCLUSIONS
Percutaneous TDE and needle interruption should be the
initial treatment of choice for posttraumatic chylous effusion
because there is a high success rate and minimal complica-
tions. This constellation of interventions does require expe-
rience in thoracic duct catheterization and expertise in
performing lymphangiography. The latter procedure is not
routinely performed in most centers, and the skills required
are disappearing. In addition, dedicated lymphangiogram
pumps are not manufactured any longer and the operators
need to rely on substitute equipment, such as the Harvard
pump (Harvard Apparatus, Holliston, Mass). As an alterna-
tive, ultrasound-guided groin lymph node injection could be
performed to opacify the cisterna chyli and thoracic duct
(unpublished data). We hope that with the development ofery c March 2010
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giography will increase and the skills will be redeveloped.
We continue to work to improve the technical success that
is directly related to the ability to visualize and cannulate
the cisterna chyli and thoracic duct. Visualization of the tho-
racic duct has improved significantly since we started to use
the saline flush (push lymphangiogram). The reverse Tren-
delenburg position of a patient may further improve cisterna
chyli opacification using gravity to slow the flow in the tho-
racic duct.23 From our limited experience, the retrograde
transvenous or direct approach through the subclavian vein
facilitates catheterization of the thoracic duct and seems to
be less technically challenging.References
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Dr N. Altorki (New York, NY). I have no disclosures. Dr Itkin, I
want to congratulate your group, but especially Dr Cope, for devel-
oping this in 1998, perfecting it, and really advocating it. For de-
cades the treatment of choice for high-volume chylous fistula has
been surgical ligation of the thoracic duct, and over the years sev-
eral important lessons have been learned. Foremost among these
lessons is the need for prompt return to the operating room, usually
within 7 or nomore than 10 days from the index procedure, to avoid
the deleterious effects of nutritional and immunologic depletion.
Second, it is critical that surgeons involved in the treatment of
chylous fistula have an intimate knowledge of thoracic duct anat-
omy because only precise identification and ligation of the duct
will work. In a few cases, video-assisted techniques are ideally
suited for that procedure. The cumulative effect of that is a success
rate in excess of 95% and a procedure-related mortality of less than
1%. There are only a few reasons why thoracic duct ligation does
not work: The duct is not ligated, there is an accessory duct, which
is rare, or there is the misfortune, as I had, of performing a medias-
tinal node dissection in a patient with liver cirrhosis that you did not
fully appreciate. That is a big problem.
Against that backdropwe are presented with your data, which are
truly impressive and noteworthy: a 71% success rate on an inten-
tion-to-treat basis and 88% on the basis of treatment actually deliv-
ered. In thoracic duct cannulation, when successful, and it is only
successful two thirds of the time, the leak can be stopped in 90%
of those in whom the duct is cannulated. If it is not cannulated, tho-
racic duct interruption by the needle is a poor alternative and also
works about two thirds of the time. So what is a thoracic surgeon
to do balancing the two? I think it will all depend on the available
institutional expertise and the cost/benefit analysis of one versus
the other, including the length of hospital stay. So my first question
is, what happened to the 32 patients in whom your intervention was
not successful? Howwere they treated and what was their outcome?
Dr Itkin. We didn’t collect these data, but to my knowledge
these patients underwent thoracic surgery and thoracic duct ligation
was performed.
Dr Altorki. What was the outcome?
Dr Itkin. I don’t have the data.
Dr Altorki. I suspect that the greatest impediment to wider
adoption of this technique is not going to be the thoracic surgeon
but rather the interventional radiology community. How well do
you think that procedure was received by the general interventional
radiology community?
Dr Itkin. Unfortunately, there is only one place I am aware of
that does this procedure on a routine basis. I think the Clevelandrdiovascular Surgery c Volume 139, Number 3 589
General Thoracic Surgery Itkin et al
G
T
SFoundation published a study 2 years ago. Other than that, I get oc-
casional reports about this procedure from my colleagues in inter-
ventional radiology. I get a weekly telephone call regarding this
procedure.
The major obstacle is the lymphangiogram. The older physicians
know how to do that, but they don’t have the equipment, and the
equipment is not currently manufactured. Right now we have
a standing order on eBay to buy any lymphangiogram pump in
the world. And obviously the new generation of interventional
radiologists don’t know how to perform a lymphangiogram.
Lymphatic intervention became my passion, so we are develop-
ing more lymphatic procedures, such as percutaneous image-
guided lymphatic ligation, to treat postoperative lymphocele. In
the animal laboratory we are trying to develop the technique to treat
obesity with some thoracic duct intervention and T-cell depletion
therapy for the bone marrow transplant recipient as a treatment
for graft-versus-host disease. So I am hoping that in the near future
lymphatic intervention will become more common, people will
start making equipment, and physicians will start to learn how to
perform a lymphangiogram.
Dr Altorki.My last question has to do with the fact that you had
one asymptomatic glue embolus, and, to me, that is a harrowing
thing if it occurs in the interventional radiology suite, a relatively
uncontrolled situation. Have you modified your technique? Does
it have to do with the amount of glue you inject? Does it have to
do with whether you inject the coils first or the glue first? Has it
gone up through the systemic venous circulation and down the su-
perior vena cava, or did you just mention that it went through the
inferior vena cava?
Dr Itkin. Generally, the amount of glue we inject is approxi-
mately 1.5 mL; so if we spill one third of that, it is only 0.5 mL of
glue. This specific case was a healthy patient who was shot in the
chest through the mediastinum, and the only injured vessel was
the lymphatic duct, and he could tolerate this complication well.
We have another article in process that is dedicated to nontrau-
matic chylous effusion (in this article, we presented only traumatic
cases), and in which we describe 1 symptomatic case of pulmonary
embolization with glue. The operator probably over-injected the
glue into the thoracic duct. In this case, the glue spilled antegrade
through the thoracic duct into the subclavian vein and then into
the pulmonary circulation. In my case, the glue was spilled retro-
grade into the inferior vena cava and then further into the pulmo-
nary circulation. Since then, we routinely put the first coil to
create the matrix for glue polymerization and then the glue is in-
jected below this level. But absolutely, we modified this technique.
This physician was injecting glue only, but now we embolize with
coils and glue simultaneously.
DrAltorki. Thank you, andmay I transfer my patients who have
liver cirrhosis to you?
Dr Itkin.Not yet. The truth is, we are summarizing these data of
nontraumatic chylothorax, and whenever we have the data, we will
have answers.
Dr J. Cooper (Philadelphia, Pa). I came to the University of
Pennsylvania and heard about this, and I can honestly tell you
that I was not initially enthusiastic, but I have to say that Dr Itkin
and colleagues have been a tremendous support. There are several
patients, some of my own, who had an esophagectomy under cir-590 The Journal of Thoracic and Cardiovascular Surgcumstances in which I really did not want to go back to the operat-
ing room because of postoperative problems, and his ability to deal
with this in those situations has been a tremendous resource.
Max, when I first heard you discuss this, I said, no, it is not pos-
sible. I don’t care how good they are, they cannot cannulate the tho-
racic duct. May I point out, if I am correct, and it makes it more
believable, that what you do is access the cisterna chyli and then
through the cisterna cannulate up to the thoracic duct. Perhaps I
am wrong, but that was my understanding, and this is what allows
you to have such a high rate of access, or are you actually punctur-
ing the thoracic duct itself?
Dr Itkin. Truthfully, whatever target I see, I go after, and I don’t
care what it is. If it is some duct that contributes to the cisterna chyli,
I will take that. Is it difficult? Yes, but as you know with experience
comes success. We managed to embolize a 1-month-old child 3
weeks ago. Embolization was technically successful but partially
clinically successful. We will try to repeat TDE in this child. It is
challenging and definitely requires some expertise.
And, one more time, thank you for the saline flush you taught me
about. It does help to see the thoracic duct better. We are thinking
about different ways to improve visualization of the thoracic duct
and cisterna chyli.
Dr S. Bolukbas (Wiesbaden, Germany). Do you combine your
approach post-interventionally with your low-fat diet, which may
lower the intraduct pressure and facilitate the closure of the thoracic
duct?
Dr Itkin. If the embolization is successful, we usually see it the
next day if the output drops to zero the day after the procedure. If
the output is reduced but not dropped, we know that the thoracic
duct is filled inadequately with glue. If it is completely unsuccess-
ful, something went wrong with our procedure and we have to think
about some other cause of chylothorax. But absolutely, a low-fat
diet is a part of the arsenal of the treatment of the chylothorax.
Dr D. Sugarbaker (Boston, Mass). I congratulate you on a ter-
rific presentation and your group for your leadership in this area. At
the Brigham, we have been following your lead for several years
and have found this to be a tremendous advantage for patients,
particularly after pleural pneumonectomy or esophagectomy. Not
having to go back or re-anesthetize the patient can often make
the difference in terms of their speedy postoperative recovery. It
is a tremendous advantage.
Could you comment on your initial approach? Is it with a coil in
each case? Is that changing now as some of the new glues, as you
mentioned, are coming along?
Dr Itkin.We have been using the same approach for the last 3
years. First, we put 2 or 3 coils just below the leak, or some other
abnormality, such as collaterals, and then we inject the glue below
the coils. The disadvantage of glue is that its setting time is several
seconds. So injection has to be performed extremely fast. One of
my colleagues started to use the Onyx embolic system, where
you have complete control over the injection; it can be injected
within 20 minutes. I personally still use glue because I did in al-
most 70 cases and feel comfortable with that. But we have to put
coils before the glue. There are occasional situations, such as un-
successful ligation to the thoracic duct, in which there is not
enough space to place a coil in the thoracic duct stump. In that
case you use only glue.ery c March 2010
